DTC vs XERS
DTC (DTC) versus Xeris Pharmaceuticals Inc (XERS) — a side-by-side from cached financials, not a winner call.
DTC (DTC) common stock.
Xeris Pharmaceuticals Inc (XERS) is a biotechnology company listed on US.
DTC does not have a complete income-statement cache yet.
Latest reported XERS revenue for 2026-06-30 was $175.2M. Net income was -$28.9M. XERS currently screens at market cap $760.7M.
XERS currently screens at market cap $760.7M.
Not investment advice. Open the DTC and XERS stock pages for the full models.
Not investment advice.